Amphastar Pharmaceuticals, Inc.

AMPH Q2 2025

Reported: 2025-08-08

Amphastar Pharmaceuticals reported Q2 2025 net revenues of $174.4 million, driven by robust sales of BAQSIMI, which jumped 21% year-over-year, underscoring the strength of its diversified portfolio.

Key takeaways

BAQSIMI recorded its highest quarterly sales at $46.7 million, marking a 21% increase from the prior year.
Total revenues decreased 4% due to heightened competition in legacy products, yet steady performance in Primatene MIST indicated resilient consumer demand.
Amphastar announced a significant expansion of its California manufacturing facility, aimed at quadrupling domestic capacity to strengthen supply chain resilience.
The company remains optimistic about regulatory approvals, particularly for its AMP-002 and AMP-015 product candidates, with key GDUFA dates approaching.
Continued investment in R&D is a priority, with expenses rising 14% year-over-year to support future growth initiatives.

View recap

Apple Hospitality REIT, Inc.

APLE Q2 2025

Reported: 2025-08-08

Apple Hospitality REIT demonstrated resilience amidst economic uncertainty, with sequential improvement in RevPAR and continued robust cash flow, supporting an attractive dividend yield.

Key takeaways

RevPAR declines moderated throughout the quarter, with July showing year-over-year growth.
Comparable hotel EBITDA margin remained strong at 37.4%, affirming operational efficiency.
Nearly 60% of hotels experienced no new construction in surrounding areas, enhancing risk profile.
Paid distributions of approximately $57 million, representing an annual yield of about 8.2%.
Executed strategic asset sales and acquisitions, optimizing portfolio concentration and capital deployment.

View recap

Arhaus Inc. Class A Common Stock

ARHS Q2 2025

Reported: 2025-08-08

Arhaus achieved record net revenues in Q2 2025, signaling resilience amid economic pressures, while showing strong momentum heading into Q3 with a 15.7% increase in demand comparable growth in July.

Key takeaways

Highest quarterly net revenue in Arhaus' history, aided by the efficient operation of the new Dallas Distribution Center.
Demand comparable growth declined in Q2 but rebounded with a 15.7% increase in July, bringing year-to-date growth to 2.2%.
Launch of the new Arhaus Bath Collection marks a strategic expansion into personal home spaces, reinforcing commitment to quality craftsmanship.
Ongoing investment in product development emphasizes customization and artistry, with collections inspired by global artisans.
Leadership transition with new CFO Michael Lee expected to strengthen operational and financial strategy moving forward.

View recap

Aspen Aerogels, Inc.

ASPN Q2 2025

Reported: 2025-08-08

Aspen Aerogels reported Q2 2025 revenues of $78 million, marking a 34% year-over-year decline, though results came in at the higher end of expectations, reflecting ongoing operational improvements and a commitment to profitability.

Key takeaways

Adjusted EBITDA expected to double in the second half of 2025 due to cost optimization efforts and streamlined operations.
Significant cost reductions of approximately $65 million achieved, aligning operational expenses with 2022 levels.
Energy & Industrial segment revenue declined 38% year-over-year, primarily impacted by a slowdown in Subsea project activities.
Plans for new CFO Grant Thoele to enhance financial strategy and transition smoothly from departing CFO Ricardo Rodriguez by Q3.
Strong outlook for 2026 with anticipated recovery in subsea and LNG project revenues driven by favorable market conditions.

View recap

Adtalem Global Education Inc.

ATGE Q4 2025

Reported: 2025-08-08

Adtalem Global Education reported robust financial performance for fiscal year 2025, achieving significant revenue growth and strategic advancements in enrollment and student outcomes amidst a challenging educational landscape.

Key takeaways

Revenue rose to $1.79 billion, a 12.9% increase year-over-year, driven by over 10% average enrollment growth across all segments.
Adjusted EBITDA margin expanded by 190 basis points to 25.7%, with adjusted earnings per share up 33% to $6.67.
Generated $283 million in free cash flow while reducing Term Loan B by $100 million and decreasing borrowing costs by 75 basis points.
Successful partnerships, particularly with SSM Health, enhance direct employment pathways for students and align education more closely with workforce needs.
Recognition from the Carnegie Foundation highlights Adtalem's commitment to access and positive post-graduation outcomes in the health care sector.

View recap

Altice USA, Inc.

ATUS Q2 2025

Reported: 2025-08-08

Altice USA's Q2 2025 performance reflects continued progress in subscriber retention and operational efficiencies, achieving notable improvements in broadband trends and video margins, while launching innovative financing solutions.

Key takeaways

Reduced broadband subscriber net losses to 35,000, a 31% year-over-year improvement, driven by effective churn reduction and localized offers.
Video subscriber losses improved to 58,000, marking the best performance in ten quarters, alongside expanded video margins.
Launched a $1 billion asset-backed loan, enhancing capital structure and reducing financing costs, signaling market confidence in cash flow stability.
Optimum Fiber recognized for fastest and most reliable internet speeds, contributing to a 1.5% year-over-year footprint expansion.
Engaged AI initiatives are streamlining operations and enhancing customer experience while optimizing network performance.

View recap

Bridger Aerospace Group Holdings, Inc. Common Stock

BAER Q2 2025

Reported: 2025-08-08

Bridger Aerospace reported record Q2 revenues of $30.8 million, marking a 100% increase year-over-year, alongside a positive net income of $0.3 million—demonstrating unprecedented performance amidst heightened wildfire activity.

Key takeaways

Achieved over 100% revenue growth compared to Q2 last year, reaching $30.8 million.
Recorded positive net income of $0.3 million, the earliest Q2 profit in company history.
Expanded deployment with all six Super Scoopers mobilized in Alaska for the first time, enhancing wildfire response capabilities.
Secured multiple long-term task orders, reflecting strong acceptance and utilization of aerial firefighting assets in a year-round context.
FMS and Ignis Technologies are positioned for future growth, with ongoing bidding opportunities and enhanced operational capabilities.

View recap

Brookdale Senior Living Inc.

BKD Q2 2025

Reported: 2025-08-08

Brookdale Senior Living reported solid performance in Q2 2025, driven by improved occupancy and significant EBITDA growth, while focusing on operational efficiency and portfolio optimization.

Key takeaways

Same-community occupancy increased to 82.8% in June and 83.3% in July, surpassing the critical 80% cash flow inflection point.
Adjusted EBITDA grew by 19.7% quarter-over-quarter, reflecting a 23.4% increase year-to-date.
Adjusted free cash flow reached $20 million, a turnaround from a negative $6 million in the same quarter last year.
G&A expenses were reduced by $850,000 quarter-over-quarter and $1.2 million year-over-year, underscoring ongoing cost management efforts.
Brookdale's strategic focus continues on maximizing occupancy and rate growth while streamlining its real estate portfolio, with plans to exit 55 leased assets by year-end.

View recap

Cliq Digital AG

CLIQ.DE Q2 2025

Reported: 2025-08-08

Cliq Group faced significant operational challenges due to new regulatory standards in the digital payments sector, leading to a withdrawal of its 2025 financial outlook. Despite these hurdles, the company improved its EBITDA margin through cost control measures.

Key takeaways

Total group sales declined to EUR 98 million in H1 2025, down from EUR 141 million in H1 2024, reflecting the impact of external pressures.
EBITDA increased by over 30% to EUR 6.5 million, resulting in an improved margin of 7%, up from 3% year-over-year.
Customer acquisition costs were halved to EUR 27 million, although the customer base decreased to 600,000, indicating a focus on efficiency.
Second quarter sales dipped by only 4% quarter-on-quarter, with adjusted sales showing growth of 3% when excluding currency fluctuations.
Management has opted to forgo a public partial share repurchase to preserve liquidity amid current uncertainties.

View recap

CompoSecure Inc. Class A Common Stock

CMPO Q2 2025

Reported: 2025-08-08

CompoSecure reported strong Q2 2025 performance, with non-GAAP net sales rising 10% year-over-year to $119.6 million, driven by robust domestic demand and advancements from its operating initiatives.

Key takeaways

Pro forma adjusted EBITDA increased 26% to $46.3 million, reflecting operational efficiencies and organic growth.
The company raised its full-year guidance, now expecting non-GAAP net sales of approximately $455 million and adjusted EBITDA of around $158 million.
There is a notable increase in premium card program refreshes and new market entrants, indicating thriving growth within the metal card segment.
CompoSecure's ongoing implementation of the CompoSecure Operating System is expected to enhance operational efficiency and drive long-term performance improvements.

View recap

DocGo Inc. Common Stock

DCGO Q2 2025

Reported: 2025-08-08

DocGo delivered strong performance in Q2 2025, highlighted by a substantial cash flow increase and strategic cost reductions, positioning the company for growth amid increasing demand for proactive healthcare solutions.

Key takeaways

Cash flow from operations exceeded $30 million, contributing to a total cash balance of $128.7 million at quarter-end.
Implementation of substantial SG&A reductions is projected to generate $10 million in annualized savings.
Operational metrics met targets with over 176,000 medical transports and significant progress in care gap closure programs.
Customer engagement has surged, with over 1.2 million assigned lives served, and a 50% increase in patient conversions compared to the prior quarter.
Ongoing expansion efforts with significant contracts in new markets position DocGo for robust growth through 2026.

View recap

Definitive Healthcare Corp. Class A Common Stock

DH Q2 2025

Reported: 2025-08-08

Definitive Healthcare reported Q2 2025 results that exceeded expectations, reflecting improved renewal rates and strong operational efficiencies despite a year-over-year revenue decline.

Key takeaways

Total revenue was $60.8 million, down 5% year-over-year but above guidance; early signs of improved renewal rates were noted.
Adjusted EBITDA reached $18.7 million, representing a 31% margin, supported by disciplined expense management and scalable operations.
New logo activity remained robust, indicating strong customer demand for the company's differentiated healthcare data solutions.
Highest retention rate since Q2 of last year reinforces positive momentum, despite upcoming larger renewal periods in December and January.
Guidance for revenue and adjusted EBITDA has been increased, reflecting confidence from first-half performance.

View recap

Ginkgo Bioworks Holdings Inc. Class A Common Stock

DNA Q2 2025

Reported: 2025-08-08

Ginkgo Bioworks reported a significant reduction in cash burn and costs, achieving a $250 million annual run rate savings three months ahead of schedule while guiding for continued revenue growth in 2025.

Key takeaways

Cell Engineering revenue increased by 8% year-over-year to $39 million, with a 10% rise in revenue-generating programs.
Total adjusted EBITDA improved by 72%, reducing losses to $28 million from $99 million a year ago.
Successful restructuring resulted in a 63% decrease in R&D expenses and a 57% drop in G&A expenses.
Cash burn was reduced to $38 million, down from $110 million in the same quarter last year, enabling a stronger cash position of $474 million.
Full-year revenue guidance for 2025 remains unchanged, with expectations of $167 million to $187 million, reflecting strategic growth initiatives.

View recap

Krispy Kreme Inc. Common Stock

DNUT Q2 2025

Reported: 2025-08-08

Krispy Kreme's Q2 2025 performance reflects a strategic pivot toward international franchise growth and operational efficiencies, with an emphasis on margin expansion and deleveraging initiatives.

Key takeaways

Completed the sale of Insomnia Cookies and halted the quarterly cash dividend to strengthen the balance sheet.
Actively refranchising operations in key international markets and restructuring the joint venture with WKS Restaurant Group to reduce ownership stake.
Closed over 750 underperforming U.S. delivery points and prioritized opening 1,100 more profitable high-volume doors, enhancing route profitability.
Achieved double-digit digital sales growth, which now constitutes over 20% of total U.S. retail sales.
Launched a multimedia marketing campaign for the Original Glazed doughnut, resulting in early positive sales momentum.

View recap

Medical Facilities Corporation

DR.TO Q2 2025

Reported: 2025-08-08

Medical Facilities Corporation reported a mixed Q2 2025 with a decline in consolidated revenue impacted primarily by operational challenges at Sioux Falls Specialty Hospital, though other facilities showed strong performance and profitability.

Key takeaways

Overall facility service revenue decreased 1.3% to $80.6 million, largely due to reduced surgical volumes at Sioux Falls; excluding this hospital, revenue increased 6.5%.
Surgical case volumes dipped 0.9% overall, but showed a slight increase of 0.1% when excluding Sioux Falls, while outpatient cases rose by 0.7%.
Share repurchases totaled $6.9 million in Q2, contributing to a 18% reduction in outstanding shares year-to-date, returning $52.2 million to shareholders.
A new three-year $40 million credit agreement with CIBC enhances financial flexibility and includes an option to expand the facility by an additional $25 million under specific conditions.
EBITDA for the quarter declined 4.7% to $16 million, but when excluding Sioux Falls, income from operations surged nearly 99%.

View recap

Element Fleet Management Corp.

EFN.TO Q2 2025

Reported: 2025-08-08

Element Fleet Management achieved record results in Q2 2025, driven by robust top-line growth, disciplined expense management, and strategic client expansions, setting a strong trajectory for the year.

Key takeaways

Adjusted earnings per share rose 7% year-over-year to $0.30, while free cash flow per share increased 8% to $0.40.
Net revenue increased 6% year-over-year to $290 million, with services revenue growing 8% and net financing revenue up 4% despite foreign exchange headwinds.
The company welcomed 46 new clients and expanded its service enrollments by 265, enhancing its recurring revenue base.
The creation of Element Mobility and new partnerships with industry leaders signal a strategic pivot toward integrated, tech-enabled solutions.
Adjusted return on equity improved to 17.5%, reflecting effective capital management and operational efficiencies.

View recap

Enovis Corporation Common Stock

ENOV Q2 2025

Reported: 2025-08-08

Enovis reported solid second-quarter performance, achieving 7% revenue growth and a strong shift towards improved margins under new CEO Damien McDonald’s leadership.

Key takeaways

Revenue increased to $2.2 billion, up from $1.4 billion since the spin-off, supported by successful acquisitions and organic growth.
Adjusted EBITDA margins improved from 14% to nearly 18%, reflecting operational enhancements and disciplined capital allocation strategies.
Strong demand and effective cash management led to positive cash flow, amid challenges from tariffs.
The company is prioritizing commercial execution, innovation, and operational excellence to drive future growth and enhance patient outcomes.
Continued focus on embedding financial discipline across the organization to reduce costs and improve working capital efficiency.

View recap

ESCO Technologies Inc.

ESE Q3 2025

Reported: 2025-08-08

ESCO Technologies delivered a stellar Q3 2025 performance with strong revenue growth across its Aerospace & Defense and Test segments, underpinned by strategic acquisitions and improved margins.

Key takeaways

Aerospace & Defense revenue surged nearly 20% year-over-year, driven by robust orders for Virginia and Columbia Class submarines.
Adjusted EPS guidance raised, projecting over 20% growth compared to the previous year.
The Test segment reported a 21% revenue increase, with margins stabilizing at mid-teen levels.
Strategic divestitures and acquisitions enhance market focus, particularly in Navy markets.
Strong order growth across utility services indicates sustained demand amid evolving energy needs.

View recap

Expensify Inc. Class A Common Stock

EXFY Q2 2025

Reported: 2025-08-08

Expensify reported a year-over-year revenue increase to $35.8 million in Q2 2025 amidst recognition of multiple years of film-related expenses, leading to a net loss of $8.8 million. The company's brand awareness surged significantly following its prominent feature in an F1 movie.

Key takeaways

Revenue grew to $35.8 million, with total interchange also up year-on-year at $5.3 million.
Free cash flow increased by 10% year-over-year to $6.3 million, prompting a raised annual guidance of $19 million to $23 million.
Significant brand awareness boost, including a 350% rise among the critical 18-24 age demographic, attributed to exposure from the F1 movie that featured the Expensify logo extensively.
Seasonality effects noted in July with member count dropping to 641,000, although generally expected during summer months.
Continued investment in global bank support with over 10,000 banks integrated, enhancing the platform's appeal internationally.

View recap

FRP Holdings, Inc.

FRPH Q2 2025

Reported: 2025-08-08

FRP Holdings reported a significant decline in net income for Q2 2025, impacted mainly by legal expenses and lower interest income, while pro rata net operating income (NOI) showed a modest 5% increase year-over-year.

Key takeaways

Net income fell 72% to $600,000 ($0.03 per share), down from $2 million ($0.11 per share) due to due diligence-related expenses.
Pro rata NOI increased to $9.7 million, driven by stronger contributions from multifamily and mining royalty segments, which were up 5% and 21%, respectively.
Industrial and Commercial segment NOI decreased by 15% to $1 million, heavily affected by lease expirations and tenant defaults, resulting in a focus on increasing occupancy.
Anticipated flat NOI growth through 2025 as the company works to lease vacancies in key projects, with expectations for resumed growth into 2026.
New joint ventures in Florida are set to add over 1.8 million square feet of industrial real estate by 2026, potentially generating an annual NOI of $9 million.

View recap

Genpact Limited

G Q2 2025

Reported: 2025-08-08

Genpact Limited delivered a strong Q2 2025 performance, with revenues of $1.25 billion and an 11% year-over-year increase in adjusted EPS, outpacing revenue growth and reflecting solid operational execution.

Key takeaways

Revenue increased by 7% year-over-year, driven by broad-based business outperformance.
Advanced Technology Solutions revenue surged 17% year-over-year, bolstered by increased demand for AI-driven services and solutions.
Adjusted operating income margins expanded by 40 basis points, highlighting effective margin management amid ongoing strategic investments.
Partnerships contributed significantly to growth, with partner-related revenues rising over 70% year-over-year, now accounting for 10% of total revenue.
The company is focused on integrating AI into core operations, with 70% of Advanced Technology Solutions revenue being annuitized, ensuring sustained growth and client retention.

View recap

GDI Integrated Facility Services Inc.

GDI.TO Q2 2025

Reported: 2025-08-08

GDI Integrated Facility Services reported a 5% year-over-year revenue decline in Q2 2025, primarily due to organic shrinkage; however, adjusted EBITDA margins improved to 6%.

Key takeaways

Total revenue for Q2 2025 was $610 million, down $29 million from Q2 2024, primarily due to a 4% organic decline.
Adjusted EBITDA remained stable at $34 million, with margins improving 1% year-over-year.
Business Service Canada saw a slight revenue increase, while U.S. operations faced challenges due to low-margin account adjustments post-Atilan acquisition.
The Technical Service segment performed well with a $14 million adjusted EBITDA, benefiting from a strong project backlog and favorable HVAC conditions.
GDI remains focused on enhancing its client retention and cost structure to navigate market uncertainties and margin pressures.

View recap

Genie Energy Ltd.

GNE Q2 2025

Reported: 2025-08-08

Genie Energy's Q2 2025 results showcased a 16% increase in consolidated revenue driven by strong growth in renewables, despite pressure on margins due to rising wholesale energy costs.

Key takeaways

Consolidated revenue rose to $105.3 million, with Genie Retail's revenue climbing 14% and Genie Renewables' revenue increasing by 57%.
Customer base at Genie Retail expanded by 15% year-over-year, with improved churn rates dropping to 4.8%.
Gross profit decreased 30% to $23.5 million, impacted by a 20% rise in electricity costs and a 52% increase in natural gas costs.
Genie returned capital to shareholders through share repurchases and a quarterly dividend, maintaining a commitment to $40 million–$50 million in adjusted EBITDA for 2025.
The company is reassessing its early-stage solar projects due to changes in federal tax incentives while investing in promising ventures outside traditional energy sectors.

View recap

Grindr Inc. Common Stock

GRND Q2 2025

Reported: 2025-08-08

Grindr reported a robust second quarter, achieving a 27% year-over-year revenue growth to $104 million and reaffirming its full-year financial guidance.

Key takeaways

Adjusted EBITDA margin was 43%, indicating strong operational efficiency despite rising expenses.
Average monthly active users (MAUs) grew 6% year-over-year to 14.9 million, with paying users up 16% to 1.2 million.
Indirect revenue surged 39% year-over-year to $17 million, benefiting from new advertising partnerships and international expansion.
Net income improved to $17 million, reversing the prior year's loss, with a GAAP EPS of $0.08.
Free cash flow for the quarter was $37 million, bolstering a strong cash position of approximately $121 million.

View recap

Groupon, Inc.

GRPN Q2 2025

Reported: 2025-08-08

Groupon's Q2 2025 results reflect strong revenue growth and strategic momentum, with global billings up 12% year-over-year, bolstered by robust performance in core local categories.

Key takeaways

Global billings growth accelerated to 12% YoY, driven primarily by a 20% increase in North America Local Billings.
Free cash flow reached $25 million, showcasing the company’s capability for profitable expansion.
Full-year billings guidance raised from 3-5% to 7-9%, indicating strong business momentum and growth prospects.
Leadership transitions in the executive team aim to strengthen operational capacity and continue the transformation journey.
Positive early results from AI-generated traffic are seen as a future growth driver, enhancing the company’s marketplace positioning.

View recap

Knight Therapeutics Inc.

GUD.TO Q2 2025

Reported: 2025-08-08

Knight Therapeutics reported strong second-quarter results, achieving record adjusted revenues of CAD 108.5 million, a 15% year-over-year increase, alongside significant strategic business development activities.

Key takeaways

Adjusted EBITDA for Q2 2025 reached CAD 15.5 million, translating to CAD 0.16 per share, indicating strong operational performance.
The oncology and infectious disease portfolios saw robust growth, with revenue increases of 20% and 26% respectively, driven by new product launches and strategic transactions.
The company expanded its product offerings significantly, adding over 50 products through recent acquisitions, enhancing future growth potential.
Gross margin slightly declined to 46% due to product mix changes and severance costs from operational restructuring.
A new $50 million revolving credit facility has been secured, with plans to increase it to support ongoing acquisitions and growth initiatives in Canada and Latin America.

View recap

HireQuest, Inc.

HQI Q2 2025

Reported: 2025-08-08

HireQuest reported a 12% decline in total revenue year-over-year for Q2 2025, driven by softer market conditions and challenges in franchise renewals, yet maintained profitability with strong margins.

Key takeaways

Total revenue decreased to $7.6 million, down from $8.7 million in Q2 2024, primarily due to lower franchise royalties.
System-wide sales showed a sequential increase of 6%, highlighting resilience despite tough market dynamics.
Net income was $1.1 million or $0.08 per diluted share, compared to $2 million or $0.15 per diluted share in the prior year, reflecting the impact of increased transaction expenses.
Cost control measures led to approximately $1 million in savings in workers' compensation expenses, supporting continued profitability.
The company remains well-positioned for growth, backed by a strong balance sheet with only $4.3 million in debt.

View recap

Integral Ad Science Holding Corp. Common Stock

IAS Q2 2025

Reported: 2025-08-08

IAS reported a robust 16% revenue growth in Q2 2025, achieving a 35% adjusted EBITDA margin, driven by strong demand for its innovative CTV and performance products.

Key takeaways

Expanded partnerships include a two-year renewal with Samsung and new deals with major broadcasters like Australia SBS.
Significant customer wins include contracts with a global apparel company and a luxury retailer, demonstrating IAS’s competitive edge in measurement and optimization solutions.
Launched new product offerings, including contextual category reporting for Meta platforms and attention measurement for Snapchat, enhancing advertiser transparency and performance.
International markets now account for over 50% of new adoption for the ramping Prebid Social Optimization offering, signaling strong global demand.
Full year guidance raised, reflecting expectations for continued market momentum and growth.

View recap

Iovance Biotherapeutics, Inc.

IOVA Q2 2025

Reported: 2025-08-08

Iovance Biotherapeutics reported strong Q2 2025 performance with revenue of $60 million, driven by the successful rollout of Amtagvi, and announced a strategic restructuring to improve margins and operational efficiency.

Key takeaways

Revenue grew 22% sequentially to $60 million, with Amtagvi infusions contributing $54 million.
The company reaffirms 2025 revenue guidance of $250 million to $300 million, underpinned by strong demand for Amtagvi.
A strategic restructuring, including a 19% workforce reduction, is projected to yield over $100 million in annual cost savings starting Q4 2025.
Gross margin stood at 31%, with expectations for improvement through reduced costs of sales and enhanced manufacturing capacity utilization.
Strong real-world data indicates a nearly 49% response rate for Amtagvi, with plans to onboard large community practices in Q4 2025.

View recap

nLIGHT, Inc.

LASR Q2 2025

Reported: 2025-08-08

nLIGHT, Inc. reported a robust second quarter in 2025 with revenues of $61.7 million, driven by exceptional growth in aerospace and defense (A&D) revenues, which accounted for record sales amid increasing defense priorities.

Key takeaways

Total revenues increased 22% year-over-year, with A&D revenue surging 48.6% to a record $40.7 million due to strong directed energy product deliveries.
Record development revenue reached $20.9 million, growing over 30% sequentially and year-over-year, signaling robust demand.
The company anticipates continued growth in A&D revenue, projecting a 40% increase in 2025, supported by significant contracts and a growing pipeline of directed energy systems.
Commercial revenue from industrial and microfabrication grew sequentially to $21 million, though down 9% from the prior year, reflecting strategic adjustments in investment across markets.
nLIGHT's strategic focus on enhancing production capabilities and its alignment with U.S. Department of Defense priorities positions it advantageously for ongoing and future growth.

View recap

LifeStance Health Group Inc. Common Stock

LFST Q2 2025

Reported: 2025-08-08

LifeStance Health delivered strong second-quarter performance with 11% revenue growth, achieving double-digit margins and improved clinician productivity, prompting an increase in full-year adjusted EBITDA guidance.

Key takeaways

Revenue grew to $345 million, up 11% year-over-year, driven by a 12% increase in visit volume.
Added 173 clinicians, totaling 7,780, contributing to enhanced service capacity and productivity.
Achieved adjusted EBITDA of $34 million, with margins expected to remain in the double digits for the year.
Implemented a clinician cash incentive program and advanced tech initiatives, including AI solutions to improve operational efficiency.
Strong free cash flow of $57 million, the highest in company history, supports future growth investments.

View recap

LexinFintech Holdings Ltd.

LX Q2 2025

Reported: 2025-08-08

LexinFintech Holdings reported strong second quarter 2025 results, highlighted by a 16% revenue increase and a record net profit, demonstrating resilience through effective risk management and strategic growth initiatives.

Key takeaways

Total GMV rose 2.4% quarter-over-quarter to RMB 52.9 billion, with net profit achieving RMB 511 million, a 19% increase from the previous quarter and a remarkable 126% year-over-year growth.
Plans for shareholder value enhancement include raising the cash dividend payout ratio from 25% to 30% and a new $60 million share repurchase program.
Significant growth in the installment e-commerce segment, with GMV increasing by 139% year-over-year during the June 18 shopping festival, supported by product portfolio expansion and partnerships with top-tier brands.
Continued investment in AI has improved operational efficiency, with AI models enhancing various business areas including post-loan management and customer interaction strategies.

View recap

MDA Ltd.

MDA.TO Q2 2025

Reported: 2025-08-08

MDA Space Limited reported strong second quarter 2025 results, with revenue growth of 54% year-over-year and notable improvements in profitability, driven by a robust backlog and strategic contract wins.

Key takeaways

Q2 revenues reached $373 million, while adjusted EBITDA rose to $76 million, resulting in a margin of 20.4%.
The contract with EchoStar, valued at $1.8 billion, positions MDA as a leader in the nonterrestrial network market, with total backlog increasing to over $6 billion.
The strategic acquisition of SatixFy Communications enhances MDA's satellite systems capabilities amid growing demand for digital satellite communications.
The company’s updated 2025 revenue guidance projects $1.57 billion to $1.63 billion, a year-over-year increase of approximately 48%.

View recap

Mistras Group, Inc.

MG Q2 2025

Reported: 2025-08-08

MISTRAS Group experienced a strong second quarter in 2025, achieving record adjusted EBITDA of $24.1 million, driven by strategic diversification and notable growth in key markets despite challenges in oil and gas.

Key takeaways

Record adjusted EBITDA of $24.1 million, a nearly 9% increase year-over-year, reflecting improved operating leverage.
Organic growth of over 14% in the International segment and over 30% in the PCMS service offering within Data Solutions.
Solid growth in aerospace and defense (7.4%) and industrials (7.2%), positioning the company well for continued performance despite oil and gas market softness.
Recent NADCAP certification enhances MISTRAS' competitive position and supports growth in the aerospace sector.
Strong customer engagement efforts are guiding capital investments and R&D to meet evolving demands effectively.

View recap

Miller Industries, Inc.

MLR Q2 2025

Reported: 2025-08-08

Miller Industries reported a challenging second quarter in 2025, with a significant 42.4% year-over-year drop in net sales due to reduced demand and elevated channel inventory, but managed to improve gross margins and reduce debt.

Key takeaways

Net sales decreased to $214 million, down from $371.5 million in Q2 2024, primarily driven by a 30% fall in order intake.
Gross profit margin improved to 16.2%, reflecting a favorable product mix despite lower chassis volumes.
Achieved a cash balance of $31.8 million and reduced debt by $20 million to $55 million during the quarter.
Strategic cost reduction initiatives are being implemented to align operations with current demand, alongside proactive measures to manage tariff impacts.
Continued monitoring of inventory levels and channel health to support recovery as market conditions evolve.

View recap

Maximus, Inc.

MMS Q3 2025

Reported: 2025-08-08

Maximus reported robust performance in Q3 FY2025, achieving a 24% increase in adjusted diluted earnings per share and 15% growth in adjusted EBITDA amid ongoing shifts in governmental policy.

Key takeaways

Adjusted diluted EPS reached $2.16, up 24% year-over-year, reflecting strong operational performance.
Revenue increased 4.3% year-over-year to $1.35 billion, driven by organic growth.
The company is well-positioned to leverage new Medicaid and SNAP legislative changes, anticipating increased demand for their services over the next 18 to 24 months.
Successful contract modifications with state clients indicate growing confidence in the U.S. Services segment's growth trajectory.
Maximus focuses on delivering technology-led solutions to enhance efficiencies and user experiences in governmental services.

View recap

Orion Engineered Carbons S.A.

OEC Q2 2025

Reported: 2025-08-08

Orion S.A. reported solid Q2 2025 results with adjusted EBITDA of $69 million, reflecting operational improvements amidst ongoing demand challenges in both the rubber and specialty segments.

Key takeaways

Adjusted EBITDA of $69 million was consistent with expectations, driven by enhanced manufacturing performance.
Year-over-year volume increased by 3%, but there was a sequential decline of over 4.5% due to demand headwinds.
Specialty product lines demonstrated resilience, with higher-growth segments like conductive grades for batteries showing a strong commercial trajectory.
Management anticipates a recovery in rubber segment demand by late 2025 or early 2026, contingent on tariff clarifications impacting tire imports.
A strategic shift towards debt reduction over share repurchases reflects proactive capital allocation in a challenging market environment.

View recap

Olaplex Holdings Inc. Common Stock

OLPX Q2 2025

Reported: 2025-08-08

Olaplex Holdings, Inc. reported second-quarter fiscal 2025 net sales of $106.3 million, a 2.3% year-over-year increase, alongside a strong adjusted EBITDA margin of 23.1%, signaling progress in its transformation strategy.

Key takeaways

Direct-to-consumer sales grew low double digits, benefiting from a revamped website and optimized promotional strategies.
Non-payroll sales and marketing investments rose to $45.4 million, enhancing brand demand and contributing to a leading position in the prestige hair care market.
Despite a decline in specialty retail sales, improved sell-through rates were noted, reinforcing the impact of strategic marketing efforts.
Ongoing brand initiatives include a refreshed brand identity and targeted campaigns, expected to bolster long-term growth and consumer engagement.

View recap

Peakstone Realty Trust

PKST Q2 2025

Reported: 2025-08-08

Peakstone Realty Trust demonstrated significant progress in its transformation to an industrial REIT, driven by strong growth in its industrial outdoor storage (IOS) portfolio and continued efforts to divest from its office assets.

Key takeaways

Achieved over 25% increase in IOS annualized base rent since the start of the year following two acquisitions totaling $52 million.
Sold 11 office properties year-to-date for $216 million, reflecting a focused strategy to exit the office segment, now reduced to 35% of net book value.
Reported Q2 revenue of approximately $54 million, with net loss of $265 million primarily due to noncash impairments of $286 million linked to office properties.
Maintained strong liquidity of approximately $356 million, with a focus on reducing leverage as evidenced by a modest increase in net debt to adjusted EBITDAre from 6.4x to 6.6x.
Declared a dividend of $0.10 per share for Q3 2025, illustrating commitment to returning value amid strategic transitions.

View recap

Playtika Holding Corp.

PLTK Q2 2025

Reported: 2025-08-08

Playtika's Q2 2025 results showed $696 million in revenue, reflecting an 11% year-over-year increase, yet experienced a 1.4% sequential decline primarily driven by challenges in the Slotomania title.

Key takeaways

Disney Solitaire achieved a $100 million annual run rate, highlighting the effectiveness of Playtika's acquisition strategy and collaboration with Disney & Pixar Games.
Bingo Blitz continued strong performance with $160.2 million in revenue, alongside record D2C revenue, underscoring its leadership in the category.
Playtika has increased its long-term D2C revenue target from 30% to 40%, aiming to mitigate margin pressures during a transitional period in its portfolio.
Slotomania saw a significant revenue drop of 35.4% year-over-year, prompting the company to prioritize efforts on stabilizing its game economy.
The company is actively developing new games and expanding its portfolio to drive future growth, with a new slot game anticipated in Q4 2025.

View recap

SMA Solar Technology AG

S92.DE Q2 2025

Reported: 2025-08-08

SMA Solar Technology AG reported a challenging first half of 2025, with revenues declining to EUR 685 million and significant one-time effects impacting profitability, yet free cash flow improved significantly.

Key takeaways

Group sales decreased 9.7% year-over-year to EUR 685 million, driven by a 48% decline in the Home & Business Solutions (HBS) division.
Reported EBITDA dropped to EUR 9 million from EUR 81 million in the previous year, primarily due to one-time inventory write-offs and provisions totaling over EUR 50 million.
Free cash flow showed a substantial turnaround at EUR 66 million, reflecting improved net working capital management.
The total order backlog remains strong at EUR 1.2 billion, indicating a solid pipeline for future growth.
The Large Scale and Project Solutions division reported growth in EBIT to EUR 113 million, counterbalancing declines in the HBS division's profitability.

View recap

Sight Sciences Inc. Common Stock

SGHT Q2 2025

Reported: 2025-08-08

Sight Sciences reported solid Q2 2025 results, achieving $19.6 million in revenue and raising its full-year revenue guidance to $72 million to $76 million due to robust growth in its Surgical Glaucoma segment.

Key takeaways

Surgical Glaucoma revenue increased by 12% sequentially, although it was down 5% year-over-year, highlighting resilience amidst evolving market conditions.
The company achieved record high ordering accounts, up 6% sequentially, signaling effective client reengagement and new account acquisition.
Strong early traction and positive surgeon feedback from the recently launched OMNIEdge technology are expected to bolster future utilization and growth.
Maintained focus on operational excellence with high gross margins and diligent expense management, confirming commitment to long-term shareholder value.
Continued efforts to secure positive reimbursement coverage for TearCare, aligning with broader market opportunities in minimally invasive glaucoma treatments.

View recap

Savaria Corporation

SIS.TO Q2 2025

Reported: 2025-08-08

Savaria Corporation reported a strong Q2 2025, achieving a record adjusted EBITDA margin of 20.6% and demonstrating robust operational efficiencies through the Savaria One program.

Key takeaways

Revenues increased 2.4% year-over-year, totaling $226.7 million, fueled by a favorable foreign exchange impact and the acquisition of Western Elevator.
Consolidated gross margin improved to 39%, up 150 basis points year-over-year, reflecting enhanced operational efficiencies.
Net earnings rose 43% year-over-year to $16.3 million, with earnings per share reaching $0.23.
Patient Care segment experienced 4.4% growth, attributed to increased project work in long-term care facilities.
The company remains optimistic about growth prospects, particularly with the upcoming launch of new products and expansion initiatives.

View recap

SharkNinja, Inc.

SN Q2 2025

Reported: 2025-08-08

SharkNinja delivered impressive Q2 2025 results, showcasing a 16% year-over-year net sales growth and a substantial 33% increase in adjusted EBITDA, all while maintaining a disciplined approach to operating expenses.

Key takeaways

Achieved nearly 14% domestic sales growth and over 20% international growth, reflecting strong global demand for SharkNinja products.
Operating expenses decreased by more than 200 basis points as a percentage of net sales compared to the prior-year quarter.
Successfully diversified production with approximately 90% of U.S. volume sourced outside of China, enhancing competitive advantages amid global supply challenges.

View recap

SenesTech, Inc.

SNES Q2 2025

Reported: 2025-08-08

SenesTech reported a remarkable second quarter for FY 2025, achieving record revenues and gross profit margins driven by a 94% year-over-year increase in sales of its Evolve Rodent Birth Control solution.

Key takeaways

Quarterly revenue hit an all-time high with Evolve sales constituting 83% of total revenues.
Gross profit margins improved to 65.4%, up from 54.2% year-over-year, signaling strong financial health.
E-commerce sales surged 78% year-over-year, making up over 50% of total sales, with Amazon as a primary growth driver.
Significant expansion into brick-and-mortar retail, with a nearly 500% sequential sales increase, bolstered by a partnership with Bradley Caldwell.
Sales to city and government verticals grew over 500% year-over-year, reflecting strong demand and trial deployments in major urban areas.

View recap

Solventum Corporation

SOLV Q2 2025

Reported: 2025-08-08

Solventum delivered robust Q2 results, surpassing expectations with a strong sales growth and raised EPS guidance, driven by innovative product launches and ongoing strategic initiatives.

Key takeaways

Q2 sales growth exceeded projections, prompting management to raise full-year sales growth and EPS guidance.
Successful execution of a comprehensive ERP implementation, marking a significant milestone despite facing initial challenges.
Reduced estimated tariff impact for 2025, showcasing effective mitigation strategies in response to evolving trade policies.
Continued momentum in MedSurg business, with a positive outlook for Advanced Wound Care and solid demand for IV site management products.
Strategic focus on five key growth drivers, expected to contribute over 80% of long-term growth, enhancing operational clarity and direction.

View recap

SoundHound AI Inc Class A Common Stock

SOUN Q2 2025

Reported: 2025-08-08

SoundHound achieved an outstanding Q2 2025 with revenue soaring to $43 million, a 217% year-over-year increase, driven by robust growth across its automotive, AI customer service, and restaurant sectors.

Key takeaways

Achieved record monthly processing of over 1 billion queries, underscoring rapid scalability.
Successful integration of acquisitions, enhancing capabilities and driving sustained post-merger growth.
Polaris, SoundHound's proprietary model, outperformed competitors in accuracy and cost-efficiency, solidifying its market leadership.
Continued momentum in Voice Commerce with advanced pilots in collaboration with multiple OEMs.
Strong Q2 expansion in restaurant activations and significant new contracts in automotive, particularly in international markets.

View recap

Target Hospitality Corp.

TH Q2 2025

Reported: 2025-08-08

Target Hospitality reported strong second-quarter results, underpinned by strategic contract wins and diversification within its service offerings, positioning the company for robust growth in the expanding technology and government sectors.

Key takeaways

Secured two multiyear contracts valued over $400 million, enhancing the company's diversified contract portfolio.
Continued high customer retention rates with renewals exceeding 90%, indicating strong demand for premium service offerings.
Advanced discussions for a new data center community contract, capitalizing on a $1.2 trillion investment in technology infrastructure.
Reactivation of the Dilley, Texas facility is on schedule, reinforcing Target's capabilities in government contracting amidst rising border security initiatives.
Strong growth pipeline anticipated due to increasing demand for remote hospitality solutions in emerging markets.

View recap

TSS, Inc.

TSSI Q2 2025

Reported: 2025-08-08

TSS Inc. delivered exceptional second-quarter results with a 262% year-over-year revenue increase, fueled by strong demand for high-performance computing solutions, particularly in AI applications.

Key takeaways

Total revenue surged to $44 million, significantly surpassing the $12.2 million reported in Q2 2024.
Adjusted EBITDA exceeded $4 million, reflecting over a 100% increase and strong operational efficiency.
Procurement services drove remarkable revenue growth of 572% year-over-year, reaching $33 million, largely due to federal government contracts.
Systems integration services also performed robustly, achieving a 91% revenue increase, as enterprise AI deployments gain momentum.
Positive cash flow from operations for the first half of the year reinforces financial stability and business model durability.

View recap

Yelp Inc.

YELP Q2 2025

Reported: 2025-08-08

Yelp Inc. reported impressive second-quarter results with record net revenue of $370 million, driven primarily by a robust 8% growth in services revenue, while maintaining strong profitability through disciplined expense management.

Key takeaways

Net income rose 16% year-over-year to $44 million, achieving a 12% net income margin.
Adjusted EBITDA increased by 10% to $100 million, equating to a 27% margin, notably exceeding guidance.
Services revenue hit a quarterly record of $241 million, offsetting a 5% decline in restaurant and retail revenue.
Significant traction in AI initiatives, including a 400% increase in project submissions via Yelp Assistant, pointing to strong future growth potential.
Ongoing expense management led to reduced stock-based compensation, with efforts to decrease this further in coming years, enhancing margin quality.

View recap

Earnings Recaps

Amphastar Pharmaceuticals, Inc.

Apple Hospitality REIT, Inc.

Arhaus Inc. Class A Common Stock

Aspen Aerogels, Inc.

Adtalem Global Education Inc.

Altice USA, Inc.

Bridger Aerospace Group Holdings, Inc. Common Stock

Brookdale Senior Living Inc.

Cliq Digital AG

CompoSecure Inc. Class A Common Stock

DocGo Inc. Common Stock

Definitive Healthcare Corp. Class A Common Stock

Ginkgo Bioworks Holdings Inc. Class A Common Stock

Krispy Kreme Inc. Common Stock

Medical Facilities Corporation

Element Fleet Management Corp.

Enovis Corporation Common Stock

ESCO Technologies Inc.

Expensify Inc. Class A Common Stock

FRP Holdings, Inc.

Genpact Limited

GDI Integrated Facility Services Inc.

Genie Energy Ltd.

Grindr Inc. Common Stock

Groupon, Inc.

Knight Therapeutics Inc.

HireQuest, Inc.

Integral Ad Science Holding Corp. Common Stock

Iovance Biotherapeutics, Inc.

nLIGHT, Inc.

LifeStance Health Group Inc. Common Stock

LexinFintech Holdings Ltd.

MDA Ltd.

Mistras Group, Inc.

Miller Industries, Inc.

Maximus, Inc.

Orion Engineered Carbons S.A.

Olaplex Holdings Inc. Common Stock

Peakstone Realty Trust

Playtika Holding Corp.

SMA Solar Technology AG

Sight Sciences Inc. Common Stock

Savaria Corporation

SharkNinja, Inc.

SenesTech, Inc.

Solventum Corporation

SoundHound AI Inc Class A Common Stock

Target Hospitality Corp.

TSS, Inc.

Yelp Inc.

Community

Trending This Week

Notifications